Based on the Vaxart Inc stock forecast from 2 analysts, the average analyst target price for Vaxart Inc is USD 3.00 over the next 12 months. Vaxart Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Vaxart Inc is Very Bearish, which is based on 0 positive signals and 5 negative signals. At the last closing, Vaxart Inc’s stock price was USD 0.36. Vaxart Inc’s stock price has changed by +15.95% over the past week, -34.08% over the past month and -60.91% over the last year.
No recent analyst target price found for Vaxart Inc
No recent average analyst rating found for Vaxart Inc
Company Overview Vaxart Inc
Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California. Read Less
Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for t...Read More
Frequently Asked Questions About Vaxart Inc (VXRT) Stock
Based on ratings from 2 analysts Vaxart Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 2 buy, sell and hold ratings.
Unfortunately we do not have enough data on VXRT's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for VXRT is USD 3.00 over the next 12 months. The maximum analyst target price is USD 4 while the minimum anlayst target price is USD 2.
Unfortunately we do not have enough data on VXRT's stock to indicate if its overvalued.
The last closing price of VXRT's stock was USD 0.36.
The most recent market capitalization for VXRT is USD 0.08B.
Based on targets from 2 analysts, the average taret price for VXRT is projected at USD 3.00 over the next 12 months.
This means that VXRT's stock price may go up by +744.12% over the next 12 months.
We can't find any ETFs which contains Vaxart Inc's stock.
As per our most recent records Vaxart Inc has 105 Employees.
Vaxart Inc's registered address is 170 Harbor Way, South San Francisco, CA, United States, 94080.
You can get more information about it from Vaxart Inc's website at https://vaxart.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Vaxart Inc (VXRT) Stock
Based on ratings from 2 analysts Vaxart Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 2 buy, sell and hold ratings.
Unfortunately we do not have enough data on VXRT's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for VXRT is USD 3.00 over the next 12 months. The maximum analyst target price is USD 4 while the minimum anlayst target price is USD 2.
Unfortunately we do not have enough data on VXRT's stock to indicate if its overvalued.
The last closing price of VXRT's stock was USD 0.36.
The most recent market capitalization for VXRT is USD 0.08B.
Based on targets from 2 analysts, the average taret price for VXRT is projected at USD 3.00 over the next 12 months.
This means that VXRT's stock price may go up by +744.12% over the next 12 months.
We can't find any ETFs which contains Vaxart Inc's stock.
As per our most recent records Vaxart Inc has 105 Employees.
Vaxart Inc's registered address is 170 Harbor Way, South San Francisco, CA, United States, 94080.
You can get more information about it from Vaxart Inc's website at https://vaxart.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for VXRT !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
